Tetsuya Yoshida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tetsuya Yoshida has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Susumu Kageyama
Department of Urology, Shiga University of Medical Science, Shiga, Japan
7 shared publications Akihiro Kawauchi
Department of Urology, Shiga University of Medical Science, Shiga, Japan
4 shared publications- Akihiro Kawauchi
Department of Urology Otsu City Hospital Shiga, Otsu Japan
3 shared publications Keiji Tomita
Department of Urology, Shiga University of Medical Science, Otsu, Japan
3 shared publications- Takahiro Isono
Central Research Laboratory, Shiga University of Medical Science, Otsu, Shiga, Japan
3 shared publications - Kazuyoshi Johnin
Department of Urology Shiga University of Medical Science Ōtsu Japan
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 4 (10)
Propensity Score–Matched Comparison of Laparoscopic Transvesical Ureteral Reimplantation and Intravesical Open Ureterocystoneostomy for Primary Vesicoureteral Reflux: A Multicenter Study in Japan
Purpose: The aim of this study was to assess the real-world perioperative safety and reoperation risk of laparoscopic transvesical ureteral reimplantation (TVUR), using intravesical open ureterocystoneostomy as a reference procedure, in patients with primary vesicoureteral reflux (VUR). Materials and Methods: We retrospectively reviewed patients with primary VUR who underwent laparoscopic TVUR or intravesical open ureterocystoneostomy in Japan (2012-2022). Laparoscopic TVUR was defined as a laparoscopic intravesical (vesicoscopic) transvesical approach; robot-assisted intravesical procedures were excluded. Propensity score matching was performed using age, sex, height, weight, bilaterality, duplex ureter, ureterocele, and maximum VUR grade. The primary outcome was reoperation. Secondary outcomes included operative time, catheter removal, hospital stay, and complications. Results: Among 1330 patients (laparoscopic TVUR: n = 514; intravesical open ureterocystoneostomy: n = 816), 868 were matched (434 per group). Laparoscopic TVUR required longer operative time (median [interquartile range]: 262 [220-321] vs 182 [151-229] min; P < .001) but was associated with earlier catheter removal (3 [2-5] vs 6 [3-7] days; P < .001) and shorter hospitalization (5 [3-7] vs 7 [5-9] days; P < .001). Intraoperative and postoperative complications were more frequent with laparoscopic TVUR (4.4% vs 0.5% and 12.4% vs 4.1%, respectively; P < .001). Urinary peritonitis occurred only after laparoscopic TVUR. Reoperation was more common in this group (2.8% vs 0.7%; hazard ratio: 3.74, 95% confidence interval: 1.05-13.24; P = .041). Conclusions: In this multicenter propensity score–matched cohort of patients with primary VUR, laparoscopic TVUR was associated with earlier catheter removal and shorter hospitalization but higher complication and reoperation rates than intravesical open ureterocystoneostomy, underscoring the importance of careful patient selection and meticulous technique.
- 1 October 2026
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 4 (10)
Open AccessPropensity Score–Matched Comparison of Laparoscopic Transvesical Ureteral Reimplantation and Intravesical Open Ureterocystoneostomy for Primary Vesicoureteral Reflux: A Multicenter Study in Japan
Purpose: The aim of this study was to assess the real-world perioperative safety and reoperation risk of laparoscopic transvesical ureteral reimplantation (TVUR), using intravesical open ureterocystoneostomy as a reference procedure, in patients with primary vesicoureteral reflux (VUR). Materials and Methods: We retrospectively reviewed patients with primary VUR who underwent laparoscopic TVUR or intravesical open ureterocystoneostomy in Japan (2012-2022). Laparoscopic TVUR was defined as a laparoscopic intravesical (vesicoscopic) transvesical approach; robot-assisted intravesical procedures were excluded. Propensity score matching was performed using age, sex, height, weight, bilaterality, duplex ureter, ureterocele, and maximum VUR grade. The primary outcome was reoperation. Secondary outcomes included operative time, catheter removal, hospital stay, and complications. Results: Among 1330 patients (laparoscopic TVUR: n = 514; intravesical open ureterocystoneostomy: n = 816), 868 were matched (434 per group). Laparoscopic TVUR required longer operative time (median [interquartile range]: 262 [220-321] vs 182 [151-229] min; P < .001) but was associated with earlier catheter removal (3 [2-5] vs 6 [3-7] days; P < .001) and shorter hospitalization (5 [3-7] vs 7 [5-9] days; P < .001). Intraoperative and postoperative complications were more frequent with laparoscopic TVUR (4.4% vs 0.5% and 12.4% vs 4.1%, respectively; P < .001). Urinary peritonitis occurred only after laparoscopic TVUR. Reoperation was more common in this group (2.8% vs 0.7%; hazard ratio: 3.74, 95% confidence interval: 1.05-13.24; P = .041). Conclusions: In this multicenter propensity score–matched cohort of patients with primary VUR, laparoscopic TVUR was associated with earlier catheter removal and shorter hospitalization but higher complication and reoperation rates than intravesical open ureterocystoneostomy, underscoring the importance of careful patient selection and meticulous technique.
- 19 May 2025
- Published by Wiley in International Journal of Urology
- Vol. 32 (9) , 1165-1171
Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study ( ROBOHIT Trial)
Objectives: We aimed to evaluate the long‐term oncological and functional outcomes after robot‐assisted partial nephrectomy (RAPN) for renal hilar tumors. Methods: A total of 22 academic hospitals in Japan participated in a prospective, multicenter, single‐arm, open‐label trial with a 2‐year enrollment period. After undergoing RAPN, 105 patients with clinical T1 renal hilar tumors were followed up for 5 years and evaluated. Recurrence‐free survival, overall survival, and trends of renal function were set as oncological and functional outcomes. Results: Five‐year overall survival and recurrence‐free survival were 98.0% and 89.2%, respectively. Mean estimated glomerular filtration rates (eGFRs) were 69.031 mL/min preoperatively, and were 59.374, 58.334, 58.221, 56.975, and 59.602 mL/min at 1, 2, 3, 4, and 5 years after surgery, respectively. While eGFR was significantly lower than the preoperative one at all points ( p < 0.001), eGFRs at 1 and 5 years after surgery did not differ significantly ( p = 0.793). Conclusion: After long‐term follow‐up, RAPN for clinical T1 renal hilar tumors continues to provide functional and oncological outcomes equivalent to those in the perioperative period. Trial Registration: The study protocol was registered in the Japan Registry of Clinical Trials (jRCT1052190005, UMIN000023968)
- 19 May 2025
- Published by Wiley in International Journal of Urology
- Vol. 32 (9) , 1165-1171
Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study ( ROBOHIT Trial)
Objectives: We aimed to evaluate the long‐term oncological and functional outcomes after robot‐assisted partial nephrectomy (RAPN) for renal hilar tumors. Methods: A total of 22 academic hospitals in Japan participated in a prospective, multicenter, single‐arm, open‐label trial with a 2‐year enrollment period. After undergoing RAPN, 105 patients with clinical T1 renal hilar tumors were followed up for 5 years and evaluated. Recurrence‐free survival, overall survival, and trends of renal function were set as oncological and functional outcomes. Results: Five‐year overall survival and recurrence‐free survival were 98.0% and 89.2%, respectively. Mean estimated glomerular filtration rates (eGFRs) were 69.031 mL/min preoperatively, and were 59.374, 58.334, 58.221, 56.975, and 59.602 mL/min at 1, 2, 3, 4, and 5 years after surgery, respectively. While eGFR was significantly lower than the preoperative one at all points ( p < 0.001), eGFRs at 1 and 5 years after surgery did not differ significantly ( p = 0.793). Conclusion: After long‐term follow‐up, RAPN for clinical T1 renal hilar tumors continues to provide functional and oncological outcomes equivalent to those in the perioperative period. Trial Registration: The study protocol was registered in the Japan Registry of Clinical Trials (jRCT1052190005, UMIN000023968)
- Open Access
- 7 August 2024
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 29 (10) , 1548-1556
Efficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: a multicenter, prospective study
Background: This study aimed to compare the efficacy of robot-assisted partial nephrectomy for completely endophytic renal tumors with the reported outcomes of conventional laparoscopic partial nephrectomy and investigate the transition of renal function after robot-assisted partial nephrectomy. Methods: We conducted a prospective, multicenter, single-arm, open-label trial across 17 academic centers in Japan. Patients with endophytic renal tumors classified as cT1, cN0, cM0 were included and underwent robot-assisted partial nephrectomy. We defined two primary outcomes to assess functional and oncological aspects of the procedure, which were represented by the warm ischemic time and positive surgical margin, respectively. Comparisons were made using control values previously reported in laparoscopic partial nephrectomy studies. In the historical control group, the warm ischemia time was 25.2, and the positive surgical margin was 13%. Results: Our per-protocol analysis included 98 participants. The mean warm ischemic time was 20.3 min (99% confidence interval 18.3–22.3; p < 0.0001 vs. 25.2). None of the 98 participants had a positive surgical margin (99% confidence interval 0–5.3%; p < 0.0001 vs. 13.0%). The renal function ratio of eGFR before and after protocol treatment multiplied by splits was 0.70 (95% confidence interval: 0.66–0.75). Factors such as preoperative eGFR, resected weight, and warm ischemic time influenced the functional loss of the partially nephrectomized kidney after robot-assisted partial nephrectomy. Conclusions: Robot-assisted partial nephrectomy for completely endophytic renal tumors offers a shorter warm ischemia time and comparable positive surgical margin rate compared with conventional laparoscopic partial nephrectomy.
- 7 August 2024
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 29 (10) , 1548-1556
Open AccessEfficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: a multicenter, prospective study
Background: This study aimed to compare the efficacy of robot-assisted partial nephrectomy for completely endophytic renal tumors with the reported outcomes of conventional laparoscopic partial nephrectomy and investigate the transition of renal function after robot-assisted partial nephrectomy. Methods: We conducted a prospective, multicenter, single-arm, open-label trial across 17 academic centers in Japan. Patients with endophytic renal tumors classified as cT1, cN0, cM0 were included and underwent robot-assisted partial nephrectomy. We defined two primary outcomes to assess functional and oncological aspects of the procedure, which were represented by the warm ischemic time and positive surgical margin, respectively. Comparisons were made using control values previously reported in laparoscopic partial nephrectomy studies. In the historical control group, the warm ischemia time was 25.2, and the positive surgical margin was 13%. Results: Our per-protocol analysis included 98 participants. The mean warm ischemic time was 20.3 min (99% confidence interval 18.3–22.3; p < 0.0001 vs. 25.2). None of the 98 participants had a positive surgical margin (99% confidence interval 0–5.3%; p < 0.0001 vs. 13.0%). The renal function ratio of eGFR before and after protocol treatment multiplied by splits was 0.70 (95% confidence interval: 0.66–0.75). Factors such as preoperative eGFR, resected weight, and warm ischemic time influenced the functional loss of the partially nephrectomized kidney after robot-assisted partial nephrectomy. Conclusions: Robot-assisted partial nephrectomy for completely endophytic renal tumors offers a shorter warm ischemia time and comparable positive surgical margin rate compared with conventional laparoscopic partial nephrectomy.
- Open Access
- 1 August 2022
- Published by The Japanese Society of Physical Fitness and Sports Medicine in Japanese Journal of Physical Fitness and Sports Medicine
- Vol. 71 (4) , 305-318
What is required for a successful tackle in rugby football? -A statistical and biomechanical analysis of tacklers and ball carriers-
In this study, we searched the relevant literature for studies involving the number of tackles and wins/losses in a rugby match, the movement of the tackler and ball carrier, the momentum of tackles, the technique and physical fitness of tacklers, and the risk of injury in order to examine the factors contributing to a successful tackle. As a result, it was found that professional players had a higher success rate of tackles than amateur players younger than 20 years of age. However, the number of tackles per match and the relationship between the success rate of tackles and the results of the match differed depending on the competitive level and the country/region. Regarding tackle movements, the success rates of shoulder tackles were higher than those of other types of tackles. High-level players performed shoulder tackles with both shoulders and both hips facing the ball carrier (body position square), with their trunk roughly parallel to the ground. Furthermore, high-level players had a high body mass; thus, they tackled with high momentum (velocity × mass). Regarding physical fitness, high-level tackling techniques required maximum strength and power in the lower and upper limbs, and also improving the maximal aerobic capacity and overall agility may help prevent fatigue and thus positively contribute to successful tackling. This review suggested that young rugby players need to improve their tackling techniques, including adopting a posture with a straight spine and leg-drive, as the risk of concussion among novices was higher than that among experts.
- 1 August 2022
- Published by The Japanese Society of Physical Fitness and Sports Medicine in Japanese Journal of Physical Fitness and Sports Medicine
- Vol. 71 (4) , 305-318
Open AccessWhat is required for a successful tackle in rugby football? -A statistical and biomechanical analysis of tacklers and ball carriers-
In this study, we searched the relevant literature for studies involving the number of tackles and wins/losses in a rugby match, the movement of the tackler and ball carrier, the momentum of tackles, the technique and physical fitness of tacklers, and the risk of injury in order to examine the factors contributing to a successful tackle. As a result, it was found that professional players had a higher success rate of tackles than amateur players younger than 20 years of age. However, the number of tackles per match and the relationship between the success rate of tackles and the results of the match differed depending on the competitive level and the country/region. Regarding tackle movements, the success rates of shoulder tackles were higher than those of other types of tackles. High-level players performed shoulder tackles with both shoulders and both hips facing the ball carrier (body position square), with their trunk roughly parallel to the ground. Furthermore, high-level players had a high body mass; thus, they tackled with high momentum (velocity × mass). Regarding physical fitness, high-level tackling techniques required maximum strength and power in the lower and upper limbs, and also improving the maximal aerobic capacity and overall agility may help prevent fatigue and thus positively contribute to successful tackling. This review suggested that young rugby players need to improve their tackling techniques, including adopting a posture with a straight spine and leg-drive, as the risk of concussion among novices was higher than that among experts.
- Open Access
- 22 October 2020
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 18 (1) , 1-11
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma
Background: Accurate prediction of the prognosis of RCC using a single biomarker is challenging due to the genetic heterogeneity of the disease. However, it is essential to develop an accurate system to allow better patient selection for optimal treatment strategies. ARL4C, ECT2, SOD2, and STEAP3 are novel molecular biomarkers identified in earlier studies as survival-related genes by comprehensive analyses of 43 primary RCC tissues and RCC cell lines. Methods: To develop a prognostic model based on these multiple biomarkers, the expression of four biomarkers ARL4C, ECT2, SOD2, and STEAP3 in primary RCC tissue were semi-quantitatively investigated by immunohistochemical analysis in an independent cohort of 97 patients who underwent nephrectomy, and the clinical significance of these biomarkers were analyzed by survival analysis using Kaplan-Meier curves. The prognostic model was constructed by calculation of the contribution score to prognosis of each biomarker on Cox regression analysis, and its prognostic performance was validated. Results: Patients whose tumors had high expression of the individual biomarkers had shorter cancer-specific survival (CSS) from the time of primary nephrectomy. The prognostic model based on four biomarkers segregated the patients into a high- and low-risk scored group according to defined cut-off value. This approach was more robust in predicting CSS compared to each single biomarker alone in the total of 97 patients with RCC. Especially in the 36 metastatic RCC patients, our prognostic model could more accurately predict early events within 2 years of diagnosis of metastasis. In addition, high risk-scored patients with particular strong SOD2 expression had a much worse prognosis in 25 patients with metastatic RCC who were treated with molecular targeting agents. Conclusions: Our findings indicate that a prognostic model based on four novel biomarkers provides valuable data for prediction of clinical prognosis and useful information for considering the follow-up conditions and therapeutic strategies for patients with primary and metastatic RCC.
- 22 October 2020
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 18 (1) , 1-11
Open AccessA risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma
Background: Accurate prediction of the prognosis of RCC using a single biomarker is challenging due to the genetic heterogeneity of the disease. However, it is essential to develop an accurate system to allow better patient selection for optimal treatment strategies. ARL4C, ECT2, SOD2, and STEAP3 are novel molecular biomarkers identified in earlier studies as survival-related genes by comprehensive analyses of 43 primary RCC tissues and RCC cell lines. Methods: To develop a prognostic model based on these multiple biomarkers, the expression of four biomarkers ARL4C, ECT2, SOD2, and STEAP3 in primary RCC tissue were semi-quantitatively investigated by immunohistochemical analysis in an independent cohort of 97 patients who underwent nephrectomy, and the clinical significance of these biomarkers were analyzed by survival analysis using Kaplan-Meier curves. The prognostic model was constructed by calculation of the contribution score to prognosis of each biomarker on Cox regression analysis, and its prognostic performance was validated. Results: Patients whose tumors had high expression of the individual biomarkers had shorter cancer-specific survival (CSS) from the time of primary nephrectomy. The prognostic model based on four biomarkers segregated the patients into a high- and low-risk scored group according to defined cut-off value. This approach was more robust in predicting CSS compared to each single biomarker alone in the total of 97 patients with RCC. Especially in the 36 metastatic RCC patients, our prognostic model could more accurately predict early events within 2 years of diagnosis of metastasis. In addition, high risk-scored patients with particular strong SOD2 expression had a much worse prognosis in 25 patients with metastatic RCC who were treated with molecular targeting agents. Conclusions: Our findings indicate that a prognostic model based on four novel biomarkers provides valuable data for prediction of clinical prognosis and useful information for considering the follow-up conditions and therapeutic strategies for patients with primary and metastatic RCC.
- Open Access
- 1 September 2020
- Published by Elsevier in JTCVS Techniques
- Vol. 3, 176-178
Coronary ostial plasty using femoral artery patch in Takayasu aortitis: A 15-year follow-up study
- 1 September 2020
- Published by Elsevier in JTCVS Techniques
- Vol. 3, 176-178
Open AccessCoronary ostial plasty using femoral artery patch in Takayasu aortitis: A 15-year follow-up study
- 6 January 2020
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 13 (4) , 519-525
Off‐clamp tumor excision using soft coagulation in laparoscopic and robotic partial nephrectomy
Introduction: The aim of this study was to assess the perioperative outcomes of off‐clamp tumor excision using soft coagulation in laparoscopic and robotic partial nephrectomy.Methods: We retrospectively analyzed the data from 78 patients who underwent minimally invasive partial nephrectomy, using soft coagulation, at the Shiga University of Medical Science, between September 2013 and April 2017. Tumor excision and hemostasis without renal arterial clamping was performed using soft coagulation. Collecting system repair and renorrhaphy with arterial clamping were carried out only if the collecting system had been opened.Results: Forty‐three of the 78 patients underwent laparoscopic partial nephrectomy using soft coagulation and the other 35 patients underwent robotic partial nephrectomy using soft coagulation. The median estimated total blood loss was 73 (0‐1140) mL and no patient needed a blood transfusion. No cases featured postoperative hemorrhagic events. Six patients with urinary fistula needed prolonged ureteral stenting. The median percentage change of the estimated glomerular filtration rate was −7.2 at one to 3 months after surgery.Conclusion: The off‐clamp soft coagulation technique in laparoscopic partial nephrectomy and robotic partial nephrectomy is a safe and feasible approach to excise kidney tumors. This procedure may reduce the incidence of perioperative hemorrhagic complications.
- 6 January 2020
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 13 (4) , 519-525
Off‐clamp tumor excision using soft coagulation in laparoscopic and robotic partial nephrectomy
Introduction: The aim of this study was to assess the perioperative outcomes of off‐clamp tumor excision using soft coagulation in laparoscopic and robotic partial nephrectomy.Methods: We retrospectively analyzed the data from 78 patients who underwent minimally invasive partial nephrectomy, using soft coagulation, at the Shiga University of Medical Science, between September 2013 and April 2017. Tumor excision and hemostasis without renal arterial clamping was performed using soft coagulation. Collecting system repair and renorrhaphy with arterial clamping were carried out only if the collecting system had been opened.Results: Forty‐three of the 78 patients underwent laparoscopic partial nephrectomy using soft coagulation and the other 35 patients underwent robotic partial nephrectomy using soft coagulation. The median estimated total blood loss was 73 (0‐1140) mL and no patient needed a blood transfusion. No cases featured postoperative hemorrhagic events. Six patients with urinary fistula needed prolonged ureteral stenting. The median percentage change of the estimated glomerular filtration rate was −7.2 at one to 3 months after surgery.Conclusion: The off‐clamp soft coagulation technique in laparoscopic partial nephrectomy and robotic partial nephrectomy is a safe and feasible approach to excise kidney tumors. This procedure may reduce the incidence of perioperative hemorrhagic complications.
- Open Access
- 20 December 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (2) , 2551-2556
Changes in renal function following nedaplatin‑containing chemotherapy in patients with urothelial carcinoma unfit for cisplatin
The present study evaluated the impact of nedaplatin‑containing chemotherapy on renal function in 35 patients with urothelial carcinoma (UC) between 2001 and 2014 who were unfit for cisplatin treatment. As comparative controls, the present study also examined 35 patients with the same disease who underwent cisplatin‑containing chemotherapy during the same period. The changes in the estimated glomerular filtration rate (eGFR) prior to and following the administration of nedaplatin during each cycle of chemotherapy was investigated. The present study also reported the overall response rates and adverse events in each group. A total of 31 cycles of the gemcitabine/nedaplatin regimen and 66 cycles of the methotrexate/epirubicin/nedaplatin regimen were administered. In the nedaplatin group, the mean eGFRs prior to and following chemotherapy were 45.4 and 47.8 ml/min/1.73 m2, respectively. The eGFR of the post‑chemotherapy group was significantly increased (P<0.001). On the other hand, in the cisplatin group, the eGFR following chemotherapy was significantly lower than the rate prior to chemotherapy (P<0.001). The overall response rates were 30.4 and 66.7% in the nedaplatin and cisplatin groups, respectively. In the two groups, myelosuppression was the most common side effect, but the occurrence rates in both groups were similar, and these adverse events were manageable. With regard to nephrotoxicity, nedaplatin‑containing chemotherapy for cisplatin‑unfit patients with UC is a safe treatment modality.
- 20 December 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (2) , 2551-2556
Open AccessChanges in renal function following nedaplatin‑containing chemotherapy in patients with urothelial carcinoma unfit for cisplatin
The present study evaluated the impact of nedaplatin‑containing chemotherapy on renal function in 35 patients with urothelial carcinoma (UC) between 2001 and 2014 who were unfit for cisplatin treatment. As comparative controls, the present study also examined 35 patients with the same disease who underwent cisplatin‑containing chemotherapy during the same period. The changes in the estimated glomerular filtration rate (eGFR) prior to and following the administration of nedaplatin during each cycle of chemotherapy was investigated. The present study also reported the overall response rates and adverse events in each group. A total of 31 cycles of the gemcitabine/nedaplatin regimen and 66 cycles of the methotrexate/epirubicin/nedaplatin regimen were administered. In the nedaplatin group, the mean eGFRs prior to and following chemotherapy were 45.4 and 47.8 ml/min/1.73 m2, respectively. The eGFR of the post‑chemotherapy group was significantly increased (P<0.001). On the other hand, in the cisplatin group, the eGFR following chemotherapy was significantly lower than the rate prior to chemotherapy (P<0.001). The overall response rates were 30.4 and 66.7% in the nedaplatin and cisplatin groups, respectively. In the two groups, myelosuppression was the most common side effect, but the occurrence rates in both groups were similar, and these adverse events were manageable. With regard to nephrotoxicity, nedaplatin‑containing chemotherapy for cisplatin‑unfit patients with UC is a safe treatment modality.
- Open Access
- 14 July 2018
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (7) , 2054
Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy
γ-Glutamylcyclotransferase (GGCT), which is one of the major enzymes involved in glutathione metabolism, is upregulated in a wide range of cancers—glioma, breast, lung, esophageal, gastric, colorectal, urinary bladder, prostate, cervical, ovarian cancers and osteosarcoma—and promotes cancer progression; its depletion leads to the suppression of proliferation, invasion, and migration of cancer cells. It has been demonstrated that the suppression or inhibition of GGCT has an antitumor effect in cancer-bearing xenograft mice. Based on these observations, GGCT is now recognized as a promising therapeutic target in various cancers. This review summarizes recent advances on the mechanisms of the antitumor activity of GGCT inhibition.
- 14 July 2018
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (7) , 2054
Open AccessMechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy
γ-Glutamylcyclotransferase (GGCT), which is one of the major enzymes involved in glutathione metabolism, is upregulated in a wide range of cancers—glioma, breast, lung, esophageal, gastric, colorectal, urinary bladder, prostate, cervical, ovarian cancers and osteosarcoma—and promotes cancer progression; its depletion leads to the suppression of proliferation, invasion, and migration of cancer cells. It has been demonstrated that the suppression or inhibition of GGCT has an antitumor effect in cancer-bearing xenograft mice. Based on these observations, GGCT is now recognized as a promising therapeutic target in various cancers. This review summarizes recent advances on the mechanisms of the antitumor activity of GGCT inhibition.